| Literature DB >> 32934508 |
Eilin K Erevik1, Torbjørn Torsheim1, Cecilie S Andreassen1, Øystein Vedaa2, Ståle Pallesen1.
Abstract
BACKGROUND: Research on cannabis has focused on lifetime use or regular/heavy use (i.e., daily or almost daily). Regular, albeit not necessarily daily, cannabis use has received less scientific attention.Entities:
Keywords: alcohol; cannabis; drug use; hashish; marijuana; nicotine; personality; polysubstance use; students
Year: 2017 PMID: 32934508 PMCID: PMC7450846 DOI: 10.1177/1455072517743427
Source DB: PubMed Journal: Nordisk Alkohol Nark ISSN: 1455-0725
Sample characteristics.
| Total sample ( | Recurrent cannabis users ( | Abstainers/low-frequency users of cannabis ( | |
|---|---|---|---|
| Mean ( | Mean ( | Mean ( | |
|
| |||
| Age in years | 24.9 (6.5) | 23.5 (3.7) | 24.9 (6.5) |
| Years of studying | 2.7 (2.2) | 2.5 (2.0) | 2.8 (2.2) |
|
| |||
| Norway | 92.4% (91.9–92.9%) | 91.6% (88.7–94.4%) | 92.8% (92.3–93.4%) |
| Europe (Norway not included) | 4.4% (4.0–4.8%) | 5.8% (3.4–8.2%) | 4.3% (3.8–4.7%) |
| Asia | 1.7% (1.5–2.0%) | 0.5% (0.0–1.3%) | 1.6% (1.3–1.8%) |
| Africa | 0.5% (0.4–0.7%) | 0.5% (0.0–1.3%) | 0.4% (0.3–0.6%) |
| South or Central America | 0.4% (0.3–0.6%) | 0.3% (0.0–0.8%) | 0.4% (0.3–0.5%) |
| North America | 0.5% (0.3–0.6%) | 1.3% (0.2–2.5%) | 0.5% (0.3–0.6%) |
| Oceania | 0.0% ( | 0.0% ( | 0.0% ( |
|
| |||
| Non-religious | 65.2% (64.3–66.1%) | 86.8% (83.4–90.2%) | 64.3% (63.3–65.3%) |
| Buddhism | 0.6% (0.4–0.7%) | 0.5% (0.0 –1.3%) | 0.5% (0.4–0.7%) |
| Hinduism | 0.2% (0.1–0.3%) | 0.0% ( | 0.1% (0.1–0.2%) |
| Islam | 0.9% (0.7–1.1%) | 0.5% (0.0–1.3%) | 0.8% (0.6–1.0%) |
| Judaism | 0.0% ( | 0.0% ( | 0.0% ( |
| Christianity | 31.7% (30.9–32.6%) | 11.6% (8.4–14.9%) | 32.9% (31.9–33.9%) |
| Other religion | 1.4% (1.2–1.6%) | 0.5% (0.0–1.3%) | 1.4% (1.1–1.6%) |
|
| 63.3% (62.4–64.2%) | 36.9% (32.1–41.8%) | 65.0% (64.0–65.9%) |
|
| 10.1% (9.5–10.7%) | 13.5% (10.0–16.9%) | 10.2% (9.6–10.8%) |
|
| 47.3% (46.4–48.2%) | 58.8% (53.9–63.8%) | 46.5% (45.5–47.6%) |
|
| 11.5% (10.9–12.1%) | 2.1% (0.7–3.6%) | 11.6% (11.0–12.3%) |
|
| |||
| Extroversion | 14.1 (3.6) | 14.7 (3.8) | 14.0 (3.6) |
| Agreeableness | 16.8 (2.8) | 16.4 (3.1) | 16.9 (2.8) |
| Conscientiousness | 14.7 (3.2) | 13.2 (3.5) | 14.8 (3.2) |
| Neuroticism | 11.0 (3.6) | 11.0 (3.9) | 11.0 (3.7) |
| Intellect/imagination | 14.6 (3.2) | 16.2 (3.0) | 14.5 (3.2) |
Note. Recurrent cannabis use = cannabis use 5–50 times in the last six months; Abstention or low-frequency cannabis use = cannabis use less than five times in the last six months.
SD = standard deviation; CI = confidence interval.
aTotal scores range from 5–20 for each trait.
Cannabis use among students, total n = 9391.
|
| % (95% CI) | |
|---|---|---|
| Never used | 6821 | 72.6% (71.7–73.5%) |
| Have used, but not in the last six months | 1365 | 14.5% (13.8–15.3%) |
| 1–4 times in the last six months | 722 | 7.7% (7.2–8.2%) |
| 5–50 times in the last six months | 379 | 4.0% (3.6–4.4%) |
| More than 50 times in the last six months | 104 | 1.1% (0.9–1.3%) |
CI = confidence interval.
Characteristics related to recurrent cannabis use, total n = 9287 (reference category: no use of cannabis or less than five times in the last six months).
| Recurrent cannabis use ( | Female recurrent cannabis users ( | Male recurrent cannabis users ( | |
|---|---|---|---|
|
|
|
| |
|
| |||
| Age in years | 0.98 (0.95–1.02) | 1.01 (0.95–1.07) | 0.97 (0.93–1.01) |
| Years of studying | 0.97 (0.91–1.03) | 0.93 (0.83–1.03) | 0.99 (0.91–1.07) |
|
| |||
| Norway | 1.00 | 1.00 | 1.00 |
| Europe (Norway not included) | 1.45 (0.91–2.30) | 1.79 (0.91–3.52) | 1.22 (0.65–2.29) |
| Asia | 0.44 (0.10–1.85) |
| 0.83 (0.18–3.83) |
| Africa | 1.70 (0.38–7.62) |
| 2.19 (0.46–10.45) |
| South and Central America | 0.87 (0.11–6.66) |
| 1.48 (0.18–12.17) |
| North America | 3.22 (1.20–8.64)* | 3.40 (0.74–15.66) | 3.26 (0.90–11.86) |
| Oceania |
|
|
|
|
| |||
| Non-religious | 1.00 | 1.00 | 1.00 |
| Buddhism | 0.73 (0.17–3.08) | 1.00 (0.13–7.66) | 0.57 (0.07–4.41) |
| Hinduism |
|
|
|
| Islam | 0.64 (0.15–2.74) |
| 0.94 (0.20–4.40) |
| Judaism |
|
|
|
| Christianity | 0.35 (0.25–0.48)*** | 0.38 (0.24–0.61)*** | 0.32 (0.20–0.50)*** |
| Other religion | 0.27 (0.07–1.13) | 0.37 (0.05–2.70) | 0.22 (0.03–1.65) |
|
| |||
| Female | 1.00 | − | − |
| Male | 2.67 (2.08–3.41)*** | − | − |
|
| |||
| No effect on childhood | 1.00 | 1.00 | 1.00 |
| Affected childhood | 1.33 (0.97–1.83) | 1.19 (0.73–1.93) | 1.45 (0.95–2.22) |
|
| |||
| In a relationship | 1.00 | 1.00 | 1.00 |
| Single | 1.28 (1.03–1.60)* | 1.24 (0.87–1.76) | 1.37 (1.03–1.83)* |
|
| |||
| Without children | 1.00 | 1.00 | 1.00 |
| Have child/ren | 0.27 (0.12–0.62)** | 0.12 (0.02–0.57)** | 0.45 (0.17 –1.17) |
|
| |||
| Extroversion Z | 1.31 (1.17–1.47)*** | 1.56 (1.28–1.91)*** | 1.20 (1.04–1.38)* |
| Agreeableness Z | 0.93 (0.84–1.04) | 0.74 (0.61–0.89)** | 1.04 (0.91–1.19) |
| Conscientiousness Z | 0.74 (0.67–0.83)*** | 0.86 (0.73–1.02) | 0.67 (0.59–0.77)*** |
| Neuroticism Z | 1.16 (1.04–1.30)* | 1.25 (1.04–1.50)* | 1.09 (0.94–1.26) |
| Intellect/imagination Z | 1.51 (1.33–1.70)*** | 1.55 (1.28–1.88)*** | 1.48 (1.26–1.73)*** |
|
| χ2 ( | χ2 ( | χ2 ( |
OR = odds ratio; CI = confidence interval; Z = the variable was based on z-scores.
*p < .05, **p < .01, ***p < .001.
Alcohol, nicotine and drug use among recurrent cannabis usersa and abstainers/low-frequency users of cannabis, total n = 9287.
| Recurrent cannabis users ( | Abstainers/low-frequency users of cannabis ( | Relative risks | |
|---|---|---|---|
| Outcomes | Distribution (95% CI) | Distribution (95% CI) | |
|
| |||
| Daily smoking | 7.9% (5.2–10.7%) | 1.7% (1.4–2.0%) | 4.64*** |
| Daily use of “snus” | 36.7% (31.8–41.6%) | 16.6% (15.9–17.4%) | 2.20*** |
|
| |||
| Hazardous drinking (AUDIT ≥ 8) | 59.9% (54.9–64.9%) | 44.7% (43.7–45.8%) | 1.34*** |
| Harmful drinking (AUDIT ≥ 16) | 17.2% (13.3–21.0%) | 4.6% (4.2–5.1%) | 3.71*** |
| Dependent drinking (AUDIT ≥ 20) | 10.0% (7.0–13.1%) | 1.8% (1.5–2.0%) | 5.69*** |
|
| |||
| Hallucinogens (MDMA, LSD, other) | 24.1% (19.7–28.4%) | 0.9% (0.7–1.1%) | 27.49*** |
| Stimulants (amphetamine/methamphetamine, ADHD medicines, cocaine/crack) | 18.8% (14.8–22.7%) | 1.0% (0.8–1.2%) | 19.23*** |
| Anabolic steroids | 0.3% (0.0–0.8%) | 0.1% (0.0–0.1%) | 4.71 |
| Sedatives | 9.0% (6.1–11.9%) | 0.6% (0.4–0.7%) | 15.41*** |
| Opiates (heroin and synthetic opiates) | 1.3% (0.2–2.5%) | 0.1% (0.0–0.1%) | 23.57*** |
|
| |||
| Hallucinogens (MDMA, LSD, other) | 3.7% (1.8–5.6%) | 0.1% (0.0–0.2%) | 36.66*** |
| Stimulants (amphetamine/methamphetamine, ADHD medicines, cocaine/crack) | 4.0% (2.0–6.0%) | 0.3% (0.1–0.4%) | 16.07*** |
| Anabolic steroids | 0.0% (0.0%) | 0.0% (0.0%) | 1.00 |
| Sedatives | 2.4% (0.8–3.9%) | 0.1% (0.0–0.2%) | 21.21*** |
| Opiates (heroin and synthetic opiates) | 1.1% (0.0–2.1%) | 0.0% (0.0%) | 94.27*** |
aCannabis use 5–50 times in the last six months.
bDrug use five times or more in the last six months.
CI = Confidence interval; AUDIT = Alcohol Use Disorders Identification Test.
*p < .05, **p < .01, ***p < .001.